(Q84406110)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692058%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Impact of race on biochemical disease recurrence after prostate brachytherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692058%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Kosj Yamoah

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692058%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Nelson Stone

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692058%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Richard Stock

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692058%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

20 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692058%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692058%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692058%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692058%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

5589-5600

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692058%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

The Patterns of Care Survey of radiation therapy in localized prostate cancer: similarities between the practice nationally and in minority-rich areas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

The 2010 NCCN clinical practice guidelines in oncology on prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: results of RTOG 94-12

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Local control following permanent prostate brachytherapy: effect of high biologically effective dose on biopsy results and oncologic outcomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Prognostic significance of race on biochemical control in patients with localized prostate cancer treated with permanent brachytherapy: multivariate and matched-pair analyses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Re: Prostate cancer and the androgen receptor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

The impact of CAG repeats in exon 1 of the androgen receptor on disease progression after prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

CYP3A4 genetic variant and disease-free survival among white and black men after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26183

7 January 2021

Identifiers

DOI

10.1002/CNCR.26183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692058%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference